Table 1.
Group; mean ± SD or no. | ||
---|---|---|
|
||
Characteristic | ADHD, n = 101 | Control, n = 96 |
Sex, male:female | 38:63 | 41:55 |
Age, yr | 35.83 ± 11.16 | 36.17 ± 11.17 |
IQ estimate* | 108.08 ± 14.92 | 109.68 ± 15.34 |
Inattentive symptoms† | 6.38 ± 2.04¶ | 0.55 ± 0.993¶ |
Hyperactive/impulsive symptoms† | 5.56 ± 2.24¶ | 0.79 ± 1.21¶ |
No. of errors | 27.8 ± 20.08¶ | 16.94 ± 11.26¶ |
Medication-naive | 16 | — |
Current medication | ||
Amphetamine | 10 | — |
Methylphenidate | 56 | — |
Non-stimulant | 3 | — |
Past treatment | 16 | — |
≥ 1 depressive episode (remitted)‡ | 44 | 9 |
Anxiety disorder (remitted)‡ | 23 | 5 |
Substance abuse (remitted)‡ | 18 | 7 |
Borderline personality disorder‡ | 9 | 0 |
Antisocial‡ | 3 | 0 |
Right-handed | 85 | 86 |
DTI acquisition protocol 1§ | 64 | 73 |
ADHD = attention-deficit/hyperactivity disorder; DTI = diffusion tensor imaging; SD = standard deviation.
Scores represent the average of the standard scores for the block design and vocabulary assessments of the Wechsler Adult Intelligence Scale-III.
As measured using the ADHD-DSM-IV self rating scale.
As measured using the Structured Clinical Interview for DSM-IV for axis I and axis II disorders.
First version of DTI acquisition protocol.
Significant difference between patients with ADHD and controls.